Senate LDA lobbying filing
Pfizer Inc.
Filed as: PFIZER INC.. Search lda.senate.gov for that string; the name above is this site’s casing of it, nothing else.
Reported income
not reported
Reported expenses
$3.74M
Connections in the record
Tracked program mentions1
- Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
International Supply Chain Global Access to Medicines Pandemic Preparedness
Lobbying activities5
Copyright/Patent/TrademarkCPT
March-in Framework Guidance and Policies IP Issues Digital Patent Thickets and Product Hopping
Health IssuesHCR
Pandemic Preparedness/PAHPA Drug Pricing/Inflation Reduction Act: HR7174; Medicare Price Setting
Medicare/MedicaidMMM
PBM Transparency and Reform: S1375/HH830 - Help Ensure Lower Patient (HELP) Copays Act S1542/HR6283 - Delinking Revenue from Unfair Gouging (DRUG) Act S2973 - Modernizing and Ensuring PBM Accountability Act S3430 - Better Mental Health Care, Lower Cost Drugs, and Extenders Act HR5378 - Lower Costs More Transparency Act Inflation Reduction Act /Medicare Price Setting 340B Reform Cell and Gene Therapy Access Model HR1458 - Access to Prescription Digital Therapeutics Act of 2023
Taxation/Internal Revenue CodeTAX
VICP Reform and Excise Tax
Trade (domestic/foreign)TRD
International Supply Chain Global Access to Medicines Pandemic Preparedness
Lobbyists9
- ANGELA WILES
- CATHERINE ROBINSON
- ELISSA ALBEN
- EMILY MUELLER
- FRANCISCO CARRILLO
- JENNIFER WALTON
- MATTHEW STROIA
- PAULA BURG
- STEPHEN CLAEYS
Source: U.S. Senate Lobbying Disclosure Act database. Underlined dollar figures cite the filing record on lda.senate.gov and open to that citation. Amounts shown as “not reported” are absent from the filing itself.